The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Adaptimmune Therapeutics Plc ADR’s current trading price is -78.07% away from its 52-week high, while its distance from the 52-week low is 66.38%. The stock’s price range for this period has been between $0.20 and $1.48 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.02 million for the day, a number notably higher than the average daily volume of 0.93 million over the last three months.
At present, Adaptimmune Therapeutics Plc ADR (ADAP) has a stock price of $0.32. In the previous session, the stock saw a rise, peaking at $3.0 after an opening price of $0.33. The day’s lowest price was $0.46, and it closed at $0.29.
The market performance of Adaptimmune Therapeutics Plc ADR’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.48 on 07/30/24, while the lowest value for the same duration was $0.20 on 04/01/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Adaptimmune Therapeutics Plc ADR (ADAP) has experienced a quarterly rise of 24.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 83.70M and boasts a workforce of 506 employees.
Adaptimmune Therapeutics Plc ADR: What Analysts Are Saying
As of right now, 1 analyst is rating Adaptimmune Therapeutics Plc ADR as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2918, with a change in price of -0.2101. Similarly, Adaptimmune Therapeutics Plc ADR recorded 1,434,383 in trading volume during the last 100 days, posting a change of -38.91%.
ADAP Stock Stochastic Average
As of today, Adaptimmune Therapeutics Plc ADR’s raw stochastic average for the last 50 days stands at 84.63%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 84.63%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 84.67% and 84.09%, respectively.
ADAP Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -73.17%.However, over the last six months, we can see a stronger performance of -43.52%. Over the last 30 days, the price of ADAP has fallen by 27.90%. And in the last five days, it has surged by 17.40%.
